The preventive effect of diphenhydramine on bacterial growth in propofol: A laboratory study

European Journal of Anaesthesiology

Volumn 25, Issue 9, 2008, Pages 737-740

  Guzelant A ^a   Apiliogullari, S ^b   Kara, I ^a   Turhan, V ^c   Apiliogullari, B ^a   Yilmaz, H ^b   Balasar, M ^b   Duman, A ^d  

^a KONYA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Konya State Hospital   (Turkey)

^c GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^d SELCUK UNIVERSITY   (Turkey)

Author keywords

Diphenhydramine; Drug contamination, bacterial; Infection postoperative; Lidocaine; Propofol

Indexed keywords

AGAR; ALLENIK; DIPHENHYDRAMINE; LIDOCAINE; POFOL; PROPOFOL;

ANALYSIS OF VARIANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CANDIDA ALBICANS; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; EMULSION; ESCHERICHIA COLI; FUNGUS CULTURE; GROWTH INHIBITION; INCUBATION TIME; INOCULATION; LABORATORY; NONHUMAN; POST HOC ANALYSIS; PSEUDOMONAS AERUGINOSA; RECORDING; STAPHYLOCOCCUS AUREUS; STUDENT T TEST;

ANALYSIS OF VARIANCE; ANESTHETICS, INTRAVENOUS; ANESTHETICS, LOCAL; CANDIDA ALBICANS; DIPHENHYDRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CONTAMINATION; ESCHERICHIA COLI; PROPOFOL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 49149083278     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021508004377     Document Type: Article

References (22)

1. Angelini G, Ketzler JT, Coursin DB. Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit. Crit Care Clin 2001; 17: 863-880.
2. Paul EM. Propofol: therapeutic indications and side-effects. Curr Pharm Des 2004; 10: 3639-3649.
3. McNeil MM, Lasker BA, Lott TJ, Jarvis WR. Postsurgical Candida albicans infections associated with an extrinsically contaminated intravenous anesthetic agent. J Clin Microbiol 1999; 37: 1398-1403.
4. Bennett SN, McNeil MM, Bland LA et al. Postoperative infection traced to contamination of an intravenous anesthetic, Propofol. N Engl J Med 1995; 333: 147-154.
5. Kuehnert MJ, Webb RM, Jochimsen EM et al. Staphylococcus aureus bloodstream infections among patients undergoing electroconvulsive therapy traced to breaks in infection control and possible extrinsic contamination by Propofol. Anesth Analg 1997; 85: 420-425.
6. Diprivan injection (package insert). Wilmington, DE: Zeneca Pharmaceuticals, 1996.
7. Vidovich MI, Peterson LR, Wong HY. The effect of lidocaine on bacterial growth in propofol. Anesth Analg 1999; 88: 936-938.
8. Jansson JR, Fukada T, Ozaki M, Kimura S. Propofol EDTA and reduced incidence of infection. Anaesth Intensive Care 2006; 34: 362-368. Review.
9. Nathanson MH, Gajraj NM, Russell JA. Prevention of pain on injection of propofol: a comparison of lidocaine with alfentanil. Anesth Analg 1996; 82: 469-471.
10. Apiliogullari S, Keles B, Apiliogullari B, Balasar M, Yilmaz H, Duman A. Comparison of diphenhydramine and lidocaine in preventing injection pain of propofol: a double blind, placebo controlled randomised study. Eur J Anaesthesiol 2007; 24: 235-238.
11. Weinstein MP, Moderazo E, Tilton R, Maggini G, Qintiliani R. Further observations on the antimicrobial effects of local anesthetics agents. Curr Ther Res Clin Exp 1975; 17: 369-374.
12. Semenitz E. The antibacterial activity of diphenhydramine [author's translation]. Wien Klin Wochenschr 1978; 90: 710-714. German.
13. Wachowski I, Jolly DT, Hrazdil J, Galbraith JC, Greacen M, Clanachan AS. The growth of microorganisms in propofol and mixtures of propofol and lidocaine. Anesth Analg 1999; 88: 209-212.
14. Apan TZ, Apan A, Sahin S, Cakirca M. Antibacterial activity of remifentanil and mixtures of remifentanil and propofol. J Clin Anesth 2007; 19: 346-350.
15. Winn JR, Allen S, Janda Wet al. Koneman's Colour Atlas and Text Book Of Diagnostic Microbiolgy, 6th edn. Baltimore, Philadelphia: Lippincott, William-Wilkins, 2006: p. 1162.
16. Walfson JS, Swartz MN. Serum bactericidal activity as a monitor of antibiotic therapy. N Engl J Med 1985; 312: 968-975.
17. Harrison CA, Rogers DW, Rosen M. Blood contamination of anaesthetic and related staff. Anaesthesia 1990; 45: 831-833.
18. Henry B, Plante-Jenkins C, Ostrowska K. An outbreak of Serratia marcescens associated with the anesthetic agent propofol. Am J Infect Control 2001; 29: 312-315.
19. Picard P, Tra'mer MR. Prevention of pain on injection with propofol: a quantitative systematic review. Anesth Analg 2000; 90: 963-969.
20. Ozer Z, Ozturk C, Altunkan AA, Cinel I, Oral U. Inhibition of bacterial growth by lignocaine in propofol emulsion. Anaesth Intensive Care 2002; 30: 179-182.
21. Meyer RA, Jakubowski W. Use of tripelennamine and diphenhydramine as local anesthetics. J Am Dent Assoc 1964; 69: 112-117.
22. Dastidar SG, Jairaj J, Mookerjee M, Chakrabarty AN. Studies on antimicrobial effect of the antihistaminic phenothiazine trimeprazine tartrate. Acta Microbiol Immunol Hung 1997; 44: 241-247.